Professor Meir Lahav – Leading Oncologist for Lymphoma and Hematologic malignancies

prof. Meir Lahav - leading oncologist for hematologic malignancies in Israel

Leading Oncologist Hematological  Malignancies

Position: Director in Department of Internal Medicine and Hematologic Oncology.

Hospital: Beilinson Hospital, Petah-Tikva.

Professor Meir Lahav was included in Forbes magazine’s list of the best doctors in Israel

Qualified Medical Consultation Online, Second Opinion

Ask Doctor

 


Private Medical Consultation and Second Opinion

  • Early and Metastatic stages of Hematological Malignancies
  • Bone Marrow Diseases
  • Lymphoma
  • Hematopoiesis
  • Hodgkin’s Lymphoma
  • Non-Hodgkin’s Lymphoma
  • LCC

 

Send Your Medical Files        Book Consultation Now

Professional Experience of Prof. Meir Lahav

  • Director, Department of Internal Medicine, Beilinson Hospital
  • Senior physician, Institute of Hematology, Davidoff Cancer Center , Beilinson Hospital.
  • Vice Dean, Sackler School of Medicine, Tel Aviv University
  • Founded the Senior Adult Oncology Program, Davidoff Cancer Center, Beilinson Hospital.
  • Head, Laboratory of Telomere Biology, Felsenstein Medical research Center – Beilinson Hospital and Tel Aviv University.

Education of prof. Lahav

 

  • Graduated in Sackler School of Medicine, Tel Aviv University
  • Finished Faculty of Internal Medicine, with honors, Beilinson Hospital , Petah Tikva Israel
  • Fellowship in Hematology-Oncology, Tufts University, Boston

 

Professional Associations

  • Israeli Society of Clinical Oncology and Radiotherapy.
  • Israeli Hematological Society

Scientific Research and Treatment Discoveries

Professor Meir Lahav is head of Telomere Biology Laboratory in Felsenstein Medical research Center, and cooperate with Beilinson Hospital and Tel Aviv University. The professor Lahav is published in renowned scientific and medical journals for researches related to oncological hematological diseases – more then 88 publications.

Among his last publications are studies such as :

  •  Identification of Cancer Cells in the Human Body by Anti-Telomerase Peptide Antibody – for early detection of tumor
  • Late onset neutropenia after rituximab and obinutuzumab treatment  – studying of new cancer treatment using CD-20 antibody
  • Chronic Pain and Premature Aging – The Moderating Role of Physical Exercise
  • and more

More publications of Prof. Meir Lahav :  https://pubmed.ncbi.nlm.nih.gov/

 

All Israeli Oncologists

Cancer Second Opinion

All Best Israeli Doctors for You – 2024

Call-Center for an appointment at leading doctors of Israel

Contact us if you are not sure about your health condition or diagnosis / faced with the choice of a treatment option / need second opinion of a reputable Israeli doctor  / a reliable, clear medical advice / second opinion on biopsy results / MRI / PET / CT scan / advanced medical treatment in best hospitals in Israel.

We will promptly coordinate a doctor consultation and medical treatment in Israel.

Tel / Whatsapp / Viber +972 54 803 45 32 info@resultmed.com

*Authorized by Israel Ministry of Health
מס פניה:#622301
 

In Israel you'll find

  • HIGH Medical Standard
  • INNOVATIONS - a Global Leader
  • Newest FDA Protocols
  • HIGH Treatment Outcomes Rate

!מבקרים באתר היקרים, אנא שימו לב

.אנחנו חברה תיירות מרפא. אנו נותנים שרות פרטי לתיירים בלבד